Jamal Lewis Receives Prestigious NIH MIRA Grant
Jamal Lewis has received a National Institutes of Health of Maximizing Investigators’ Research Award (MIRA) for New and Early Stage Investigators.
The grant, which will support the Lewis lab’s work to understand and exploit the phenomenon of vomocytosis, is $1.9 million over the next five years.
Professor Lewis’s research program is seeking to develop a universally-deployable, microparticle vaccine platform as an effective, long-lasting prophylactic against infectious agents.
Additionally, the research and development of this platform system has the potential to significantly transform the treatment of other immune-related conditions.